Name: Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice (Neuromethods, 173) (en Inglés)
Price: 466400.00 CLP
Availability: InStock
Author: Peplow Philip V.,Martinez Bridget,Gennarelli Thomas A.
ISBN: 9781071617113

portada Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice (Neuromethods, 173) (en Inglés)

Formato

Libro Físico

Editorial

Humana

Autor

Peplow Philip V.,Martinez Bridget,Gennarelli Thomas A.

Idioma

Inglés

N° páginas

583

Encuadernación

Tapa Dura

ISBN13

9781071617113

N° edición

Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice (Neuromethods, 173) (en Inglés)

Peplow Philip V.,Martinez Bridget,Gennarelli Thomas A. (Autor) · Humana · Tapa Dura

Libro Nuevo

$ 466.400

$ 777.340

Ahorras: $ 310.940

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 21 de Junio y el Lunes 01 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice (Neuromethods, 173) (en Inglés)"

This volume presents recent data on the latest achievements in new and emerging technologies for biomarkers and for innovations in their assessment. The chapters cover topics such as activation of microglia and macrophages in neurodegenerative diseases; oxidative stress and cellular dysfunction in neurodegenerative diseases; TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders; and imaging biomarkers in Huntington's disease and amyotrophic lateral sclerosis. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and comprehensive, Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice is a valuable resource for both experimental and clinical experts in the field of neurodegenerative diseases who are looking to expand their knowledge of novel biomarkers in different types of neurodegenerative diseases.